CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments.
Advanced bioreactors enable investigators to maintain viable tissue samples in closed systems under laboratory conditions. A multi-axis bioreactor has been designed for therapy testing to address the unmet need for the long-term culture of intervertebral discs under complex mechanical stimulation.